<DOC>
	<DOCNO>NCT00727350</DOCNO>
	<brief_summary>The study population exist patient histological diagnosis NSCLC , stage T1 , T2 T3NO fit refuse surgery . A prospective data analysis perform tumor response , potential acute late toxicity survival . A radiotherapy dose 4x15Gy 3x 20Gy give 2 week dynamic 3D-conformal arc therapy ( Novalis TM )</brief_summary>
	<brief_title>Protocol Primary Fractionated Stereotactic Body Radiation Therapy Stage T1 - T3N0 Non Small Cell Lung Carcinoma .</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . Stage T1 , T2 , T3N0M0 NSCLC , histological confirmation either biopsy cytology 2 . Maximal tumor diameter 6 cm 3 . Only T3 lesion base upon thoracic wall involvement 4 . Informed consent require 5 . Life expectancy least 6 month 6 . Age &gt; 18 . 7 . Karnofsky score ≥ 70 ECOG score ≤ 1 8 . Inoperable patient patient refuse surgery 9 . Patients measurable lesion ( accord RECIST criterion ) 1 . Diagnosis small cell lung cancer 2 . Lymph node involvement 3 . Prior radiotherapy chemotherapy lung cancer 4 . Pregnant lactate woman 5 . Known allergy CT contrast 6 . No FDGPET 7 . Mental condition render patient unable understand nature , scope , possible consequence study . 8 . Patient unlikely comply protocol , i.e. , uncooperative attitude , inability return followup visit , extreme degradation lung function test patient likely complete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>Novalis</keyword>
	<keyword>Stereotactic</keyword>
	<keyword>SBRT</keyword>
	<keyword>T1 , T2 T3NO NSCLC</keyword>
</DOC>